Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting

Margaret Lamb; Elani Wiest; Anthony Filiano; Athena Russell; Reza Yarani; Gaurav Sutrave; Nisha Durand; Rachel A Burga

doi:10.1016/j.jcyt.2023.01.006

Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting

Cytotherapy. 2023 Jun;25(6):590-597. doi: 10.1016/j.jcyt.2023.01.006. Epub 2023 Mar 10.

Authors

Margaret Lamb¹, Elani Wiest², Anthony Filiano³, Athena Russell⁴, Reza Yarani⁵, Gaurav Sutrave⁶, Nisha Durand², Rachel A Burga⁷

Affiliations

¹ Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA.
² Center for Regenerative Medicine, Mayo Clinic Florida, Jacksonville, Florida, USA.
³ Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA.
⁴ Center for Cellular Immunotherapies, Philadelphia, Pennsylvania, USA.
⁵ Steno Diabetes Center Copenhagen, Copenhagen, Denmark.
⁶ Faculty of Medicine and Health (FML), FML Medical Research Institutes, University of Sydney, Sydney Australia.
⁷ Obsidian Therapeutics, Cambridge, Massachusetts, USA. Electronic address: rachel.burga@gmail.com.

PMID: 36906481
DOI: 10.1016/j.jcyt.2023.01.006

Abstract

In this Committee Proceedings, representatives from the Early Stage Professional (ESP) committee highlight the innovative discoveries and key take-aways from oral presentations at the 2022 International Society for Cell and Gene Therapy (ISCT) Annual Meeting that cover the following subject categories: Immunotherapy, Exosomes and Extracellular Vesicles, HSC/Progenitor Cells and Engineering, Mesenchymal Stromal Cells, and ISCT Late-Breaking Abstracts.

Keywords: Expsomes; Extracellular veiscles; HSC; Immunotherapy; Mesenchymal stromal cells; Progenitor cells.

MeSH terms

Cell- and Tissue-Based Therapy*
Genetic Therapy
Humans
Immunotherapy
Mesenchymal Stem Cells*
Societies, Medical